These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2451525)

  • 1. Alterations in pulmonary protective enzymes following systemic bleomycin treatment in mice.
    Filderman AE; Genovese LA; Lazo JS
    Biochem Pharmacol; 1988 Mar; 37(6):1111-6. PubMed ID: 2451525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of metabolism as the biochemical basis of bleomycin-induced pulmonary toxicity.
    Lazo JS; Humphreys CJ
    Proc Natl Acad Sci U S A; 1983 May; 80(10):3064-8. PubMed ID: 6190169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of bleomycin-induced pulmonary fibrosis by lipopolysaccharide.
    Phan SH; Fantone JC
    Lab Invest; 1984 May; 50(5):587-91. PubMed ID: 6201676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oxygen concentration on pulmonary fibrosis caused by peplomycin in mice.
    Ekimoto H; Takada K; Takahashi K; Matsuda A; Takita T; Umezawa H
    J Antibiot (Tokyo); 1984 Jun; 37(6):659-63. PubMed ID: 6204963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intratracheal administration of bleomycin on GSH-shuttle enzymes, catalase, lipid peroxidation, and collagen content in the lungs of hamsters.
    Giri SN; Chen ZL; Younker WR; Schiedt MJ
    Toxicol Appl Pharmacol; 1983 Oct; 71(1):132-41. PubMed ID: 6195772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bleomycin-induced pulmonary toxicity and related factors to that toxicity in experimental animals].
    Okayama H
    Tsurumi Shigaku; 1986 May; 12(2):245-57. PubMed ID: 2429414
    [No Abstract]   [Full Text] [Related]  

  • 7. Ginkgo biloba inhibits bleomycin-induced lung fibrosis in rats.
    Iraz M; Erdogan H; Kotuk M; Yağmurca M; Kilic T; Ermis H; Fadillioğlu E; Yildirim Z
    Pharmacol Res; 2006 Mar; 53(3):310-6. PubMed ID: 16459098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the inhibitory potential of sulindac against the bleomycin-induced pulmonary fibrosis in wistar rats.
    Verma R; Brahmankar M; Kushwah L; Suresh B
    Environ Toxicol Pharmacol; 2013 Nov; 36(3):769-78. PubMed ID: 23958969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol alleviates bleomycin-induced lung injury in rats.
    Sener G; Topaloğlu N; Sehirli AO; Ercan F; Gedik N
    Pulm Pharmacol Ther; 2007; 20(6):642-9. PubMed ID: 17035056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of bleomycin induced pulmonary fibrosis in mice using the heme oxygenase inhibitor Zn-deuteroporphyrin IX-2,4-bisethylene glycol.
    Atzori L; Chua F; Dunsmore SE; Willis D; Barbarisi M; McAnulty RJ; Laurent GJ
    Thorax; 2004 Mar; 59(3):217-23. PubMed ID: 14985557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
    Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
    Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine strain differences in pulmonary bleomycin metabolism.
    Filderman AE; Lazo JS
    Biochem Pharmacol; 1991 Jun; 42(1):195-8. PubMed ID: 1712591
    [No Abstract]   [Full Text] [Related]  

  • 13. Common and distinct mechanisms of induced pulmonary fibrosis by particulate and soluble chemical fibrogenic agents.
    Dong J; Yu X; Porter DW; Battelli LA; Kashon ML; Ma Q
    Arch Toxicol; 2016 Feb; 90(2):385-402. PubMed ID: 26345256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of pulmonary oxygen toxicity by bleomycin treatment.
    Matalon S; Harper WV; Goldinger JM; Nickerson PA; Olszowka J
    J Appl Physiol (1985); 1985 Jun; 58(6):1802-9. PubMed ID: 2409069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elastase modifies bleomycin-induced pulmonary fibrosis in mice.
    Trajano LA; Trajano ET; Lanzetti M; Mendonça MS; Guilherme RF; Figueiredo RT; Benjamim CF; Valenca SS; Costa AM; Porto LC
    Acta Histochem; 2016 Apr; 118(3):203-12. PubMed ID: 26852294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIMP-1 is a key factor of fibrogenic response to bleomycin in mouse lung.
    Manoury B; Caulet-Maugendre S; Guénon I; Lagente V; Boichot E
    Int J Immunopathol Pharmacol; 2006; 19(3):471-87. PubMed ID: 17026855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced oxygen toxicity following treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Kehrer JP; Paraidathathu T
    Fundam Appl Toxicol; 1984 Oct; 4(5):760-7. PubMed ID: 6510607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The influence of intratracheal bleomycin instillation on peroxidative processes in rat lung tissue].
    Ledwozyw A; Ruciński T; Synowiec R
    Pol Arch Weter; 1991; 31(3-4):115-23. PubMed ID: 1726838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of aminoguanidine and antioxidant erdosteine on bleomycin-induced lung fibrosis in rats.
    Yildirim Z; Turkoz Y; Kotuk M; Armutcu F; Gurel A; Iraz M; Ozen S; Aydogdu I; Akyol O
    Nitric Oxide; 2004 Sep; 11(2):156-65. PubMed ID: 15491848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of bleomycin-induced lung fibrosis in rats by mesna.
    El-Medany A; Hagar HH; Moursi M; At Muhammed R; El-Rakhawy FI; El-Medany G
    Eur J Pharmacol; 2005 Feb; 509(1):61-70. PubMed ID: 15713430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.